MA26491A1 - SELECTIVE COX-2 INHIBITOR COMPOUNDS, ANTI-INFLAMMATORY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. - Google Patents

SELECTIVE COX-2 INHIBITOR COMPOUNDS, ANTI-INFLAMMATORY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.

Info

Publication number: MA26491A1
Authority: MA; Morocco
Prior art keywords: inflammatory; pharmaceutical compositions; same; compositions containing; inhibitor compounds
Prior art date: 1997-05-05

Application number

MA25059A

Other languages

French (fr)

Inventor

Marie Lundy Kristin

Paul Ricketts Anthony

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-05

Filing date

1998-05-04

Publication date

2004-12-20

1998-05-04 Application filed by Pfizer filed Critical Pfizer

2004-12-20 Publication of MA26491A1 publication Critical patent/MA26491A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicinal Preparation (AREA)

MA25059A 1997-05-05 1998-05-04 SELECTIVE COX-2 INHIBITOR COMPOUNDS, ANTI-INFLAMMATORY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. MA26491A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US4563597P	1997-05-05	1997-05-05

Publications (1)

Publication Number	Publication Date
MA26491A1 true MA26491A1 (en)	2004-12-20

Family

ID=21939053

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25059A MA26491A1 (en)	1997-05-05	1998-05-04	SELECTIVE COX-2 INHIBITOR COMPOUNDS, ANTI-INFLAMMATORY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.

Country Status (32)

Country	Link
EP (1)	EP0988034A1 (en)
JP (1)	JP2000513020A (en)
KR (2)	KR20010012300A (en)
CN (1)	CN1255059A (en)
AP (1)	AP9801234A0 (en)
AR (2)	AR011726A1 (en)
AU (1)	AU6932198A (en)
BG (1)	BG103852A (en)
BR (1)	BR9808720A (en)
CA (1)	CA2288759A1 (en)
DZ (1)	DZ2479A1 (en)
EA (1)	EA003696B1 (en)
GT (1)	GT199800063A (en)
HR (1)	HRP980244A2 (en)
HU (1)	HUP0001286A3 (en)
ID (1)	ID21311A (en)
IL (1)	IL132570A0 (en)
IS (1)	IS5220A (en)
MA (1)	MA26491A1 (en)
NO (1)	NO995389L (en)
NZ (1)	NZ500183A (en)
OA (1)	OA11213A (en)
PA (1)	PA8450601A1 (en)
PE (1)	PE72599A1 (en)
PL (1)	PL337003A1 (en)
SK (1)	SK148199A3 (en)
TN (1)	TNSN98059A1 (en)
TW (1)	TW590773B (en)
UY (1)	UY24989A1 (en)
WO (1)	WO1998050033A1 (en)
YU (1)	YU55899A (en)
ZA (1)	ZA983722B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6245797B1 (en)	1997-10-22	2001-06-12	Merck & Co., Inc.	Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) *	1998-05-22	2003-01-14	Pfizer, Inc.	Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) *	1998-05-22	2005-07-28	Pfizer Products Inc.	Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
EP1123091A1 (en) *	1998-10-23	2001-08-16	Merck Frosst Canada & Co.	Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
EP1637137A3 (en) *	1999-03-10	2006-07-05	G.D. Searle LLC	Method and composition for administering a cyclooxygenase-2 inhibitor to animals
WO2001034204A1 (en) *	1999-11-11	2001-05-17	Eli Lilly And Company	Oncolytic combinations for the treatment of cancer
US20020016342A1 (en) *	2000-05-15	2002-02-07	Edward Scolnick	Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor
US6924303B2 (en)	2000-06-13	2005-08-02	Wyeth	Analgesic and anti-inflammatory compositions containing COX-2 inhibitors
DE10032132A1 (en) *	2000-07-01	2002-01-17	Lohmann Therapie Syst Lts	Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
CA2422803A1 (en)	2000-08-07	2002-02-14	Vanderbilt University	Detection of cox-2 activity and anandamide metabolites
US20040209959A1 (en) *	2001-07-16	2004-10-21	Edward Hogestatt	Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
PL2266585T3 (en)	2003-05-07	2013-10-31	Osteologix As	Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
EP1651210A1 (en) *	2003-07-31	2006-05-03	Pharmacia & Upjohn Company LLC	Dispersible formulation of an anti-inflammatory agent
US20080269310A1 (en) *	2005-05-20	2008-10-30	Adrian Paul Foster	Synergistic Combinations
CA2683415C (en)	2007-04-04	2020-12-08	Sigmoid Pharma Limited	An oral pharmaceutical composition
WO2008132707A1 (en)	2007-04-26	2008-11-06	Sigmoid Pharma Limited	Manufacture of multiple minicapsules
JP5640079B2 (en)	2009-05-18	2014-12-10	シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄＰｈａｒｍａＬｉｍｉｔｅｄ	Oil droplet-containing composition
BR112012002963A2 (en)	2009-08-12	2017-10-24	Sigmoid Pharma Ltd	immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en)	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
GB201212010D0 (en)	2012-07-05	2012-08-22	Sigmoid Pharma Ltd	Formulations
GB201319791D0 (en)	2013-11-08	2013-12-25	Sigmoid Pharma Ltd	Formulations
US12109218B2 (en)	2014-12-09	2024-10-08	Aratana Therapeutics, Inc.	Compositions of grapiprant and methods for using the same
ES2907285T3 (en) *	2014-03-06	2022-04-22	Elanco Animal Health Incorporated	Grapiprant compositions and methods of use thereof
EA036036B1 (en)	2014-11-07	2020-09-16	Сигмойд Фарма Лимитед	Compositions comprising cyclosporin
EP3242557A4 (en) *	2015-01-09	2018-09-05	Jaguar Health, Inc.	Methods of treating diarrhea in companion animals
JP2023520367A (en) *	2020-03-25	2023-05-17	エスアールアイインターナショナル	lipoxygenase inhibitor
US11116737B1 (en)	2020-04-10	2021-09-14	University Of Georgia Research Foundation, Inc.	Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (en)	2020-11-30	2022-06-07	(주)이노보테라퓨틱스	Pharmaceutical composition for preventing or treating keloid or hypertrophic scar comprising Benzbromarone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3896145A (en) *	1972-07-24	1975-07-22	Hoffmann La Roche	Carbazoles
CA1319886C (en) *	1987-02-03	1993-07-06	Alberto Ferro	Mixed micelle solutions

1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/en active
- 1998-04-30 TW TW087106689A patent/TW590773B/en not_active IP Right Cessation
- 1998-05-01 PL PL98337003A patent/PL337003A1/en unknown
- 1998-05-01 SK SK1481-99A patent/SK148199A3/en unknown
- 1998-05-01 EA EA199900895A patent/EA003696B1/en not_active IP Right Cessation
- 1998-05-01 CN CN98804845A patent/CN1255059A/en active Pending
- 1998-05-01 YU YU55899A patent/YU55899A/en unknown
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 JP JP10547869A patent/JP2000513020A/en active Pending
- 1998-05-01 IL IL13257098A patent/IL132570A0/en unknown
- 1998-05-01 ID IDP980651A patent/ID21311A/en unknown
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Ceased
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/en not_active Ceased
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/en unknown
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/en not_active IP Right Cessation
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/en not_active Ceased
- 1998-05-04 UY UY24989A patent/UY24989A1/en not_active Application Discontinuation
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/en unknown
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/en unknown
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/en unknown
- 1998-05-04 PE PE1998000335A patent/PE72599A1/en not_active Application Discontinuation
- 1998-05-04 MA MA25059A patent/MA26491A1/en unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/en not_active Application Discontinuation
- 1998-05-05 AR ARP980102089A patent/AR011726A1/en unknown
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/en unknown
1999
- 1999-10-19 IS IS5220A patent/IS5220A/en unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/en unknown
- 1999-11-04 NO NO995389A patent/NO995389L/en not_active Application Discontinuation
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/en unknown

Also Published As

Publication number	Publication date
EP0988034A1 (en)	2000-03-29
TW590773B (en)	2004-06-11
EA003696B1 (en)	2003-08-28
EA199900895A1 (en)	2000-06-26
OA11213A (en)	2003-07-14
BG103852A (en)	2000-06-30
WO1998050033A1 (en)	1998-11-12
IL132570A0 (en)	2001-03-19
CA2288759A1 (en)	1998-11-12
PE72599A1 (en)	1999-08-12
AR039628A2 (en)	2005-03-02
UY24989A1 (en)	2001-10-25
HRP980244A2 (en)	1999-02-28
NZ500183A (en)	2002-04-26
AR011726A1 (en)	2000-08-30
SK148199A3 (en)	2001-09-11
AU6932198A (en)	1998-11-27
ID21311A (en)	1999-05-20
ZA983722B (en)	1999-11-04
TNSN98059A1 (en)	2005-03-15
AP9801234A0 (en)	1999-11-04
BR9808720A (en)	2000-07-11
CN1255059A (en)	2000-05-31
IS5220A (en)	1999-10-19
PA8450601A1 (en)	2000-05-24
KR20040004406A (en)	2004-01-13
KR20010012300A (en)	2001-02-15
HUP0001286A3 (en)	2000-12-28
DZ2479A1 (en)	2003-02-01
JP2000513020A (en)	2000-10-03
NO995389D0 (en)	1999-11-04
NO995389L (en)	2000-01-04
HUP0001286A2 (en)	2000-11-28
PL337003A1 (en)	2000-07-31
YU55899A (en)	2003-08-29
GT199800063A (en)	1999-10-26

Publication	Publication Date	Title
MA26491A1 (en)	2004-12-20	SELECTIVE COX-2 INHIBITOR COMPOUNDS, ANTI-INFLAMMATORY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
DZ2964A1 (en)	2004-03-15	New substituted diphenylureas, and pharmaceutical compositions containing them.
MA26548A1 (en)	2004-12-20	TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING RESORCINOL DERIVATIVES.
DZ3191A1 (en)	2001-01-11	Indazole compounds and pharmaceutical compositions inhibiting protein kinases, and methods of using the same.
MA26553A1 (en)	2004-12-20	ALPHA-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
BR9710372B1 (en)	2013-02-05	compound, and pharmaceutical composition.
DZ2086A1 (en)	2002-07-22	Substituted benzylaminopiperidines and pharmaceutical compositions containing them.
EE200000468A (en)	2002-04-15	The compounds, their use and the pharmaceutical composition
BR9805993B1 (en)	2009-05-05	aerosol pharmaceutical composition.
MA26537A1 (en)	2004-12-20	NOVEL 2-AMINOPYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2732967B1 (en)	1997-07-04	1-PHENYLPYRAZOLE-3-CARBOXAMIDES SUBSTITUTED, ACTIVE IN NEUROTENSIN, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
TR199901077A3 (en)	1999-12-21	Pharmaceutical formulations.
DZ2686A1 (en)	2003-03-29	Pulsed release oral pharmaceutical formulation.
FR2705566B1 (en)	1996-04-05	New pharmaceutical compositions.
DZ1916A1 (en)	2002-02-17	New compounds and pharmaceutical compositions containing them.
BRPI9810519B1 (en)	2012-02-22	4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical composition comprising the same.
NO20003254L (en)	2000-08-21	Anti-estrogenic steroids and pharmaceutical compositions containing the same, and their use
BR9607851B1 (en)	2009-01-13	combination and pharmaceutical formulation.
MA26673A1 (en)	2004-12-20	PHARMACEUTICAL COMPOUNDS
FR2775596B1 (en)	2004-12-24	NEW PHARMACEUTICAL COMPOSITIONS
AU7294098A (en)	1998-11-27	Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
PT1112266E (en)	2003-09-30	SUBSTITUTED 4-AMINO-2-ARYL-PYRIMIDINES, ITS PREPARATION, ITS USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
BR9911871B1 (en)	2010-10-19	phenoxyacetic acid derivatives and pharmaceutical compositions containing them.
MA26486A1 (en)	2004-12-20	PROTEASE INHIBITOR ARYL- AND HETEROARYL-THIAZOLOCETOHYDRAZIDES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MA26460A1 (en)	2004-12-20	NOVEL FARNESYLE TRANSFERASE INHIBITORS, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.